Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2026-09-09 18:45:58 ET · period of report 2026-09-04 · accession 0002024911-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-09 18:45 | 2026-09-05+ | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | M - OptEx | $0.00 | +2,179 | 2,313 | +1,626% | $0 |
| DM | 2026-09-09 18:45 | 2026-09-05+ | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | F - Tax | $386.11 | -854 | 1,828 | -32% | -$329.7K |
| D | 2026-09-09 18:45 | 2026-09-04 | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | A - Grant | $0.00 | +4,313 | 4,313 | New | $0 |
| DM | 2026-09-09 18:45 | 2026-09-05+ | BIO | ENGELHARDT EVA ANETTE | EVP, Pres, CDG | M - OptEx | $0.00 | -2,179 | 2,304 | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2026-09-05 | M | A | 1,027 | $0.00 | 1,530 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 2 | Common | Bio-Rad A Common Stock | 2026-09-05 | F | D | 369 | $386.11 | 1,161 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2026-09-06 | M | A | 1,152 | $0.00 | 2,313 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2026-09-06 | F | D | 485 | $386.11 | 1,828 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2026-09-04 | A | A | 4,313 | $0.00 | 4,313 | D | $0.00 · — to — | 4,313 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. (F3) The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2026-09-05 | M | D | 1,027 | $0.00 | 3,083 | D | $0.00 · — to — | 1,027 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| 7 | Derivative | Restricted Stock Units | 2026-09-06 | M | D | 1,152 | $0.00 | 2,304 | D | $0.00 · — to — | 1,152 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. (F4) The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |